加密货币市场最近经历了显着的波动，特别是特朗普(CRYPTO:TRUMP)代币，其价值大幅下跌超过50%。 此次下跌正值梅拉尼娅·特朗普推出新的表情包币之际，这标志着一个值得注意的事件，因为这是首次有总统家族成员进入表情包币领域。 起初，唐纳德·特朗普的TRUMP ...

Macmahon Holdings (ASX:MAH) has announced its selection as the mining services contractor for the Awak Mas Gold Project in South Sulawesi, Indonesia. The project, owned by PT Masmindo Dwi Area, a ...

Imugene (ASX:IMU), a clinical-stage immuno-oncology company, announced the dosing of the first Australian patient in the Phase 1b clinical trial of their CAR T-cell therapy, azer-cel (azercabtagene ...

The Bank of England plans to launch the Digital Pound Lab in 2025 as part of its Central Bank Digital Currency (CBDC) design phase. Collaboration with HM Treasury and global experts focuses on privacy ...

True North Copper (ASX:TNC) has completed its deed of company arrangement, officially marking a new phase for the company. This follows the completion of a conditional placement announced in November ...

Shares of homebuilder KB Home (NYSE:KBH) climbed 12.9% to $72.33 in premarket trading, following the company’s optimistic revenue forecast for 2025. KB Home projects housing revenue to range between ...

Eliza Labs, the developer behind ai16z (CRYPTO:AI16Z), has released a white paper detailing its vision for Web3-native artificial intelligence agents. The document outlines the capabilities of Eliza, ...

Roaring Kitty (CRYPTO:KITTY), known for his involvement in GameStop’s short squeeze in 2021, recently posted a Rick James-themed GIF, causing a significant rally in meme coins associated with him. The ...

Elon Musk, the billionaire owner of X (formerly Twitter), has launched a scathing critique of Australia's Sydney Morning Herald, accusing the publication of "relentlessly lying" and "boring their ...

Nu Skin Enterprises (NYSE:NUS) announced today that its subsidiary, Rhy, has finalized a significant strategic transaction with Later, a portfolio company of Summit Partners. The deal involves Rhyz ...

A U.S. appeals court has revived a whistleblower lawsuit accusing Swiss pharmaceutical giant Novartis (NYSE:NVS) of illegally incentivizing doctors to prescribe its multiple sclerosis drug, Gilenya.